RARE Ultragenyx Pharmaceutical Inc.

Fundamentals / CIK 0001515673 / USD

Ultragenyx Pharmaceutical Inc. reported $730.0M in revenue and a net loss of $524.0M for the trailing twelve months ended September 30, 2026 (up 8.1% year over year), with a -64.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RARE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$738.0M$369.0M$0-$718.6MFY 2016 Revenue: $133KFY 2016 Net Income: -$245.9M2016FY 2017 Revenue: $2.61MFY 2017 Net Income: -$302.1M2017FY 2018 Revenue: $51.49MFY 2018 Net Income: -$197.6M2018FY 2019 Revenue: $103.7MFY 2019 Net Income: -$402.7M2019FY 2020 Revenue: $271.0MFY 2020 Net Income: -$186.6M2020FY 2021 Revenue: $351.4MFY 2021 Net Income: -$454.0M2021FY 2022 Revenue: $363.3MFY 2022 Net Income: -$707.4M2022FY 2023 Revenue: $434.0MFY 2023 Net Income: -$607.0M2023FY 2024 Revenue: $560.0MFY 2024 Net Income: -$569.0M2024FY 2025 Revenue: $673.0MFY 2025 Net Income: -$575.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $673.0M $560.0M $434.0M $363.3M $351.4M $271.0M $103.7M $51.49M $2.61M $133K
Cost of Revenue -- -- -- -- -- -- -- $1.15M $1.0K --
Gross Profit -- -- -- -- -- -- -- $50.35M $2.61M --
Research & Development $750.0M $698.0M $648.0M $705.8M $497.2M $412.1M $357.4M $294.0M $231.6M $183.2M
Selling, General & Admin $349.0M $321.0M $310.0M $278.1M $220.0M $182.9M $161.5M $127.7M $99.91M $64.94M
Total Operating Expenses -- -- -- -- -- $601.1M $527.9M $422.9M $331.6M $248.1M
Operating Income -$535.0M -$536.0M -$569.0M -$648.9M -$381.7M -$330.1M -$424.2M -$371.4M -$328.9M -$248.0M
EBITDA -$500.0M -$500.0M -$543.0M -$630.7M -$368.5M -$317.9M -$415.6M -$351.8M -$323.1M -$244.6M
Interest Income $25.00M $37.00M $27.00M $11.07M $1.93M $7.04M $13.24M $9.54M $4.07M $3.79M
Income Before Tax -$571.0M -$567.0M -$609.0M -$701.7M -$453.0M -$185.4M -$399.4M -$197.1M -$318.3M -$245.8M
Income Tax Expense $4.00M $2.00M -$2.00M $5.70M $1.04M $1.21M $3.28M $514K -$16.20M $35K
Net Income -$575.0M -$569.0M -$607.0M -$707.4M -$454.0M -$186.6M -$402.7M -$197.6M -$302.1M -$245.9M
Basic EPS -$5.83 -$6.29 -$8.25 -$10.12 -$6.70 -$3.07 -$7.12 -$3.97 -$7.12 -$6.21
Diluted EPS -$5.83 -$6.29 -$8.25 -$10.12 -$6.70 -$3.07 -$7.12 -$3.97 -$7.12 -$6.21
Basic Shares Outstanding 98.6M 90.5M 73.5M 69.9M 67.8M 60.8M 56.6M 49.8M 42.5M 39.6M
Diluted Shares Outstanding 98.6M 90.5M 73.5M 69.9M 67.8M 60.8M 56.6M 49.8M 42.5M 39.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $173.0M $214.0M $136.0M $207.0M $160.0M $167.0M $139.0M $164.6M
Research & Development $154.0M $167.0M $187.0M $203.0M $216.0M $165.0M $166.0M $187.9M
Selling, General & Admin $97.00M $88.00M $88.00M $88.00M $87.00M $87.00M $87.00M $81.89M
Operating Income -$110.0M -$75.00M -$169.0M -$113.0M -$171.0M -$108.0M -$143.0M -$122.3M
EBITDA -$101.0M -$67.00M -$161.0M -$104.0M -$163.0M -$99.00M -$134.0M -$112.8M
Interest Income $3.00M $5.00M $6.00M $6.00M $6.00M $6.00M $7.00M $10.04M
Income Before Tax -$127.0M -$91.00M -$184.0M -$128.0M -$179.0M -$114.0M -$150.0M -$132.8M
Income Tax Expense -$9.00M $1.00M $1.00M $1.00M $1.00M $1.00M $1.00M $384K
Net Income -$118.0M -$92.00M -$185.0M -$129.0M -$180.0M -$115.0M -$151.0M -$133.2M
Basic EPS -$1.16 -$0.90 -$1.84 -- -$1.81 -$1.17 -$1.57 --
Diluted EPS -$1.16 -$0.90 -$1.84 -- -$1.81 -$1.17 -$1.57 --
Basic Shares Outstanding 102.1M 101.9M 100.6M -- 99.8M 98.5M 96.3M --
Diluted Shares Outstanding 102.1M 101.9M 100.6M -- 99.8M 98.5M 96.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $421.0M $174.0M $214.0M $132.9M $307.6M $713.5M $433.6M $113.4M $100.5M $161.1M
Short-Term Investments $259.0M $436.0M $363.6M $614.8M $432.6M $488.0M $321.6M $346.3M $134.0M $219.0M
Cash & Short-Term Investments $680.0M $610.0M $577.6M $747.8M $740.2M $1.20B $755.2M $459.7M $234.5M $380.1M
Accounts Receivable, Net $158.0M $122.0M $73.39M $40.45M $28.43M $23.09M $32.84M $12.74M $5.17M --
Inventory $52.00M $45.00M $33.97M $26.77M $16.23M $13.05M $11.55M $7.07M $757K --
Other Current Assets -- -- $47.62M $68.93M -- -- -- -- -- --
Total Current Assets $951.0M $817.0M $732.2M $883.9M $856.6M $1.30B $851.0M $522.4M $269.6M $401.7M
Property, Plant & Equipment, Net $244.0M $266.0M $290.6M $259.7M $141.2M $73.52M $44.35M $20.05M $21.84M $17.05M
Goodwill $44.00M $44.00M $44.41M $44.41M $44.41M $44.41M $44.41M $44.41M $44.41M --
Intangible Assets $176.0M $178.0M $166.3M $160.1M $130.8M $131.1M $129.0M $129.2M $141.5M --
Long-Term Investments $57.00M $135.0M $199.9M $149.0M $258.9M $10.51M $5.17M -- $9.97M $118.0M
Other Non-Current Assets $60.00M $63.00M $57.69M $48.34M $20.56M $8.81M $3.47M $3.51M $3.41M $1.84M
Total Non-Current Assets $581.0M $686.0M $758.8M $661.5M $665.8M $464.3M $284.5M $197.2M $221.2M $138.9M
Total Assets $1.53B $1.50B $1.49B $1.55B $1.52B $1.76B $1.14B $719.6M $490.8M $540.6M
Accounts Payable $31.00M $39.00M $42.11M $43.27M $17.14M $12.92M $12.87M $12.28M $8.89M $5.36M
Deferred Revenue (Current) -- -- -- -- $9.08M $66.57M -- -- $5.99M --
Other Current Liabilities $19.00M $4.00M $0 -- -- -- -- -- -- --
Total Current Liabilities $384.0M $344.0M $280.4M $261.2M $181.4M $189.6M $103.3M $74.72M $71.01M $60.26M
Other Non-Current Liabilities $44.00M $17.00M $12.21M $4.82M $1.00M $7.35M -- $4.76M $5.12M $6.39M
Total Non-Current Liabilities $1.22B $897.0M $935.2M $931.7M $418.5M $415.6M $378.4M $35.92M $36.28M $6.39M
Total Liabilities $1.60B $1.24B $1.22B $1.19B $599.8M $605.2M $481.7M $110.7M $107.3M $66.65M
Total Debt (incl. Leases) $36.00M $40.34M $43.17M $31.59M $41.97M $48.23M $36.99M -- -- --
Common Stock $0 $0 $82K $70K $69K $67K $58K $51K $44K $41K
Retained Earnings -$4.53B -$3.96B -$3.39B -$2.78B -$2.07B -$1.62B -$1.43B -$1.03B -$832.7M -$530.5M
Accumulated Other Comp. Income $1.00M -$1.00M $647K -$6.57M -$1.40M $689K -$147K -$633K -$5.68M $905K
Total Stockholders' Equity -$80.00M $255.0M $275.0M $352.0M $922.6M $1.15B $653.8M $608.9M $383.5M $474.0M
Total Equity -$80.00M $255.0M $275.0M $352.0M $922.6M $1.15B $653.8M $608.9M $383.5M $474.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $150.0M $125.0M $175.0M $421.0M $203.0M $176.0M $127.0M $174.0M
Short-Term Investments $116.0M $167.0M $238.0M $259.0M $222.7M $311.3M $367.4M $436.0M
Cash & Short-Term Investments $266.0M $292.0M $413.0M $680.0M $425.7M $487.3M $494.4M $610.0M
Accounts Receivable, Net $166.0M $200.0M $121.0M $158.0M $112.5M $124.5M $98.84M $122.0M
Inventory $59.00M $59.00M $55.00M $52.00M $52.20M $46.50M $46.03M $45.00M
Total Current Assets $544.0M $606.0M $657.0M $951.0M $643.2M $719.8M $699.2M $817.0M
Property, Plant & Equipment, Net $231.0M $235.0M $239.0M $244.0M $250.0M $255.8M $260.9M $266.0M
Goodwill $44.00M $44.00M $44.00M $44.00M $44.41M $44.41M $44.41M $44.00M
Intangible Assets $170.0M $172.0M $174.0M $176.0M $172.9M $174.7M $176.5M $178.0M
Long-Term Investments $135.0M $144.0M $121.0M $57.00M $22.07M $51.45M $68.56M $135.0M
Other Non-Current Assets $63.00M $63.00M $61.00M $60.00M $57.86M $60.12M $62.37M $63.00M
Total Non-Current Assets $643.0M $658.0M $639.0M $581.0M $547.2M $586.5M $612.8M $686.0M
Total Assets $1.19B $1.26B $1.30B $1.53B $1.19B $1.31B $1.31B $1.50B
Accounts Payable $45.00M $39.00M $42.00M $31.00M $40.57M $34.24M $47.45M $39.00M
Other Current Liabilities $22.00M $15.00M $17.00M $19.00M $1.24M $2.58M $3.35M $4.00M
Total Current Liabilities $389.0M $351.0M $325.0M $384.0M $340.0M $293.2M $291.7M $344.0M
Other Non-Current Liabilities $40.00M $41.00M $42.00M $44.00M $18.78M $17.40M $17.12M $17.00M
Total Non-Current Liabilities $1.17B $1.20B $1.20B $1.22B $834.3M $854.7M $869.0M $897.0M
Total Liabilities $1.56B $1.55B $1.52B $1.60B $1.17B $1.15B $1.16B $1.24B
Total Debt (incl. Leases) -- -- -- $36.00M $33.83M $36.30M $38.27M $40.34M
Common Stock $0 $0 $0 $0 $96K $96K $94K $0
Retained Earnings -$4.93B -$4.81B -$4.72B -$4.53B -$4.40B -$4.22B -$4.11B -$3.96B
Accumulated Other Comp. Income -$1.00M $0 $0 $1.00M $820K -$268K -$341K -$1.00M
Total Stockholders' Equity -$376.0M -$291.0M -$236.0M -$80.00M $10.00M $151.0M $144.0M $255.0M
Total Equity -$376.0M -$291.0M -$236.0M -$80.00M $10.00M $151.0M $144.0M $255.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$575.0M -$569.0M -$607.0M -$707.4M -$454.0M -$186.6M -$402.7M -$197.6M -$302.1M -$245.9M
Depreciation & Amortization $35.00M $36.00M $26.00M $18.22M $13.24M $12.26M $8.54M $19.54M $5.83M $3.42M
Stock-Based Compensation $153.0M $158.0M $135.0M $130.4M $105.0M $85.73M $82.00M $80.11M $68.01M $48.31M
Change in Receivables -$31.00M -$34.00M -$23.00M -$12.07M -$5.43M $9.84M -$20.10M -$7.58M -$5.17M --
Change in Inventory -$6.00M -$11.00M -$7.00M -$9.70M -$3.12M -$1.35M -$4.45M -$5.28M -$757K --
Change in Payables -- -- -- -- -- -- -- $3.37M $3.46M $2.50M
Operating Cash Flow -$466.0M -$414.0M -$475.0M -$380.5M -$338.7M -$132.2M -$345.4M -$290.6M -$253.8M -$161.0M
Capital Expenditure -$6.00M -$7.00M -$44.00M -$116.1M -$73.09M -$43.91M -$24.83M -$4.08M -$2.79M -$10.19M
Free Cash Flow -$472.0M -$421.0M -$519.0M -$496.6M -$411.8M -$176.1M -$370.2M -$294.6M -$256.6M -$171.2M
Acquisitions, Net -- $0 $0 -$75.03M $0 $0 -- -- -$142.8M --
Purchases of Investments -$186.0M -$409.0M -$526.0M -$614.7M -$1.01B -$813.2M -$692.8M -$509.8M -- --
Sales & Maturities of Investments $444.0M $413.0M $747.0M $535.0M $811.0M $640.8M $719.0M $310.2M -- --
Investing Cash Flow $236.0M -$18.00M $168.0M -$291.7M -$195.4M -$179.1M -$13.04M -$33.33M $55.48M $91.12M
Common Stock Issued -- -- -- $0 $0 $435.6M $330.4M $271.0M -- --
Financing Cash Flow $478.0M $399.0M $388.0M $501.2M $118.6M $600.3M $679.3M $336.9M $136.3M $138.7M
Net Change in Cash $252.0M -$35.00M $81.00M -$172.0M -$416.7M $290.1M $320.7M $12.48M -$61.57M $68.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$118.0M -$92.00M -$185.0M -$129.0M -$180.0M -$115.0M -$151.0M -$133.2M
Depreciation & Amortization $9.00M $8.00M $8.00M $9.00M $8.00M $9.00M $9.00M $9.54M
Stock-Based Compensation $34.00M $34.00M $30K $37.00M $37.00M $39.00M $40K $40.13M
Change in Receivables $23.00M -$62.00M $19.00M -$34.00M $6.00M -$13.00M $10.00M -$21.04M
Change in Inventory -$1.00M -$3.00M -$4.00M $0 -$5.00M $0 -$1.00M -$2.25M
Operating Cash Flow -$43.00M -$97.00M -$197.0M -$100.0M -$91.00M -$109.0M -$166.0M -$79.31M
Capital Expenditure -$2.00M -$1.00M -$1.00M -$1.00M -$1.00M -$3.00M -$1.00M -$163K
Free Cash Flow -$45.00M -$98.00M -$198.0M -$101.0M -$92.00M -$112.0M -$167.0M -$79.48M
Purchases of Investments -$39.00M -$57.00M -$131.0M -$154.0M -$16.00M -$16.00M $0 -$16.32M
Sales & Maturities of Investments -- -- -- $82.00M $136.0M $88.91M $137.1M $119.2M
Investing Cash Flow $58.00M $44.00M -$49.00M -$72.00M $117.0M $71.00M $120.0M $102.5M
Financing Cash Flow -- -- -- $394.0M $0 $83.84M $157K $2.94M
Net Change in Cash $24.00M -$49.00M -$247.0M $221.0M $26.00M $50.00M -$45.00M $24.18M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- 97.8% 100.0% --
Operating Margin -79.5% -95.7% -131.1% -178.6% -108.6% -121.8% -409.0% -721.2% -12593.5% -186471.4%
Net Profit Margin -85.4% -101.6% -139.9% -194.7% -129.2% -68.8% -388.3% -383.7% -11567.3% -184867.7%
Return on Equity (ROE) -- -223.1% -220.7% -201.0% -49.2% -16.2% -61.6% -32.5% -78.8% -51.9%
Return on Assets (ROA) -37.5% -37.9% -40.7% -45.8% -29.8% -10.6% -35.5% -27.5% -61.6% -45.5%
Current Ratio 2.48x 2.38x 2.61x 3.38x 4.72x 6.83x 8.24x 6.99x 3.80x 6.67x
Quick Ratio 2.34x 2.24x 2.49x 3.28x 4.63x 6.76x 8.13x 6.90x 3.79x 6.31x
Debt to Equity -- 0.16x 0.16x 0.09x 0.05x 0.04x 0.06x -- -- --
Revenue Growth (YoY) +20.2% +29.0% +19.5% +3.4% +29.7% +161.3% +101.4% +1871.5% +1863.9% --
Gross Profit Growth (YoY) -- -- -- -- -- -- -- +1828.3% -- --
5Y Revenue / Share Growth +53.2% +237.6% +470.8% +8346.4% +154179.4% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -64.0% -73.6% -83.7% -79.5% -86.3% -82.8% -87.0% -95.7%
Net Profit Margin -71.8% -81.7% -90.9% -85.4% -91.8% -87.3% -93.1% -101.6%
Return on Equity (ROE) -- -- -- -- -5792.0% -352.8% -381.5% -223.1%
Return on Assets (ROA) -44.1% -46.4% -47.0% -37.5% -48.7% -40.8% -41.9% -37.9%
Current Ratio 1.40x 1.73x 2.02x 2.48x 1.89x 2.45x 2.40x 2.38x
Quick Ratio 1.25x 1.56x 1.85x 2.34x 1.74x 2.30x 2.24x 2.24x
Debt to Equity -- -- -- -- 3.38x 0.24x 0.27x 0.16x
Revenue Growth (YoY) +8.1% +28.1% -2.2% +25.7% +14.7% +13.6% +27.7% +29.5%
Source: SEC EDGAR CompanyFacts (CIK 0001515673) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:25 UTC · Open in terminal